InMode Ltd. (INMD): R&D Expense
$13.32M
Year ended 2025-12-31
+2.3%
3-year compound annual growth
+7.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.32M | +1.4% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $13.14M | -2.0% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $13.41M | +7.9% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $12.43M | +30.4% | 2025-02-04, From 2022-01-01 |
| 2021-12-31 | $9.53M | +0.7% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $9.47M | +66.1% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $5.70M | +36.3% | 2022-02-10, From 2019-01-01 |
| 2018-12-31 | $4.18M | +62.3% | 2021-02-10, From 2018-01-01 |
| 2017-12-31 | $2.58M | n/a | 2020-02-18, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| InMode Ltd. (INMD) | 2025-12-31 | $13.32M | +1.4% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $69.06M | +23.4% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Conmed Corp (CNMD) | 2025-12-31 | $55.88M | +2.7% |
| LivaNova PLC (LIVN) | 2025-12-31 | $185.76M | +1.8% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
Compare INMD, TMDX, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗